NASDAQ: ELDN
Eledon Pharmaceuticals Inc Earnings Dates, Reports, Calls

Eledon Pharmaceuticals earnings were -$79.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ELDN earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$39.0M, up 197.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ELDN reported annual earnings of -$45.6M, with 26.1% growth. The next ELDN earnings date is Aug 13, 2026.

ELDN earnings history

Current Revenue
$0.0
Current Earnings
-$79.5M
Current Profit Margin
0%

ELDN Return on Equity

Current Company
-150.3%
Current Industry
-141.9%
Current Market
13.5%
ELDN's Return on Equity (-150.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ELDN Return on Assets

Current Company
-53.9%
Current Industry
-13.7%
ELDN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ELDN announces earnings.

ELDN Return on Capital Employed

Current Company
-59.65%
Current Industry
-9.6%
ELDN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELDN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELDN-$79.14M-$79.50MN/A-$0.77
EDIT-$106.88M-$108.95MN/A-$1.17
ALXO-$86.70M-$88.87MN/A-$1.49
VRXA-$80.06M-$82.24MN/A-$5.68
TRDA-$161.20M-$166.12MN/A-$3.99

ELDN earnings dates

Next earnings date
Aug 13, 2026

Eledon Pharmaceuticals Earnings Reports & History FAQ

What were Eledon Pharmaceuticals's earnings last quarter?

On ELDN's earnings call on May 7, 2026, Eledon Pharmaceuticals (NASDAQ: ELDN) reported Q1 2026 earnings per share (EPS) of -$0.33, up 312.5% year over year. Total ELDN earnings for the quarter were -$39.03 million. In the same quarter last year, Eledon Pharmaceuticals's earnings per share (EPS) was -$0.08.

If you're new to stock investing, here's how to buy Eledon Pharmaceuticals stock.

When does Eledon Pharmaceuticals report earnings?

The next ELDN earnings call is Aug 13, 2026. Add ELDN to your watchlist to be reminded of Eledon Pharmaceuticals's next earnings date.

Is Eledon Pharmaceuticals profitable or losing money?

As of the last Eledon Pharmaceuticals earnings report, Eledon Pharmaceuticals is currently losing money. Eledon Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$79.50 million, a 105.37% increase year over year.

What was ELDN's earnings growth in the past year?

As of Eledon Pharmaceuticals's earnings date in May 7, 2026, Eledon Pharmaceuticals's earnings has grown year over year. ELDN earnings in the past year totalled -$79.50 million.

What are Eledon Pharmaceuticals's earnings expectations?

The current EPS estimate for Eledon Pharmaceuticals's earnings report in Aug 13, 2026 is -$0.19.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.